Antibody therapies for lymphoma in children-Reference-Cited by-同舟云学术

Antibody therapies for lymphoma in children

Published:2016-01-19 Issue:1 Volume:2016 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

de Zwart Verena¹,Gouw Samantha C²,Meyer-Wentrup Friederike AG³

Affiliation:

1. Albert Schweitzer Hospital; Department of Pediatrics; Albert Schweitzerplaats 25 Dordrecht Netherlands 3318 AT

2. Emma Children's Hospital/Academic Medical Center; Department of Pediatric Hematology, Immunology, Rheumatology and Infectious disease; PO Box 22660 Amsterdam Netherlands 1100 DD

3. Princess Máxima Center for Pediatric Oncology; PO Box 85090 Utrecht Netherlands 3508 AB

Publisher

Wiley

Subject

Pharmacology (medical)

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/14651858.CD011181.pub2/fullpdf

Reference61 articles.

1. Treatment of pediatric B-NHL with protocol NHL-BFM-95 and rituximab: a single centre experience;Bilić;Haematologica Meeting Reports,2009

2. CD20 positive childhood B-non Hodgkin lymphoma (B-NHL): morphology, immunophenotype and a novel treatment approach: a single center experience;Bilić;Collegium Antropologicum,2010

3. Results of the addition of rasburicase and rituximab to the FAB/LMB96 chemotherapy backbone in children and adolescents with mature B-NHL: a Children's Oncology Group report;Cairo;Pediatric Blood and Cancer,2009

4. Safety, kinetics, and outcome following rituximab (R) in combination with FAB chemotherapy in children and adolescents (C+A) with stage III/IV (Group B) and BM+/CNS+ (Group C) mature B-NHL: a Children's Oncology Group report;Cairo;Journal of Clinical Oncology,2010

5. A phase I study of 90Yttrium-Ibritumomab-Tiuxetan in children and adolescents with relapsed/refractory CD20-positive non-Hodgkin's lymphoma: a Children's Oncology Group study;Cooney-Qualter;Clinical Cancer Research,2007

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MPET ² : a multi-network poroelastic and transport theory for predicting absorption of monoclonal antibodies delivered by subcutaneous injection;Drug Delivery;2023-01-10

2. Late outcomes in children and adolescents with non-Hodgkin lymphoma: A single-center experience;Journal of Cancer Research and Therapeutics;2022

3. Transport and Lymphatic Uptake of Biotherapeutics Through Subcutaneous Injection;Journal of Pharmaceutical Sciences;2021-10

4. WNT974 Inhibits Proliferation, Induces Apoptosis, and Enhances Chemosensitivity to Doxorubicin in Lymphoma Cells by Inhibiting Wnt/β-Catenin Signaling;Medical Science Monitor;2020-06-29

5. Diffusion-inspired time-varying phosphorescent decay in a nanostructured environment;Physical Review B;2020-01-22